Tickers

1. Composite Trajectory Verdict

For a pre-revenue-scale biometric identity platform with recurring revenue contracts and high cash burn, the balance sheet and cash flow statements carry the most weight because they determine the runway to achieve sustainable operations.

Composite Trajectory: Deteriorating

The balance sheet has deteriorated sharply in the first half of 2026: cash fell from $4.6 million (10-K 2025-12-31, Balance Sheet) to $1.35 million (10-Q 2026-06-30, Balance Sheet), working capital swung from a $4.3 million surplus to a $2.3 million deficit (10-Q 2026-06-30, Balance Sheet), and total stockholders' equity dropped from $8.6 million to $2.0 million (10-Q 2026-06-30, Balance Sheet). The income statement shows annual revenue growth (FY2025 net revenue $2.0 million vs. $0.9 million in FY2024 per 10-K 2025-12-31, Statement of Operations) but widening GAAP losses ($17.9 million net loss vs. $14.3 million). Quarterly revenue collapsed in Q2 2026 ($0.49 million vs. $1.44 million in Q2 2025 per 10-Q 2026-06-30, Statement of Operations). Operating cash burn improved year-over-year (H1 2026: $6.7 million used vs. $8.4 million in H1 2025 per 10-Q 2026-06-30, Cash Flows), but financing proceeds dropped from $8.2 million (equity) to $3.5 million (debt), leaving the company with a senior secured debenture maturing in October 2026 and substantial doubt about its ability to continue as a going concern (10-Q 2026-06-30, Going Concern).

2. Red Flags

• Going concern qualification in every filing with explicit "substantial doubt" language and accumulated deficit reaching $201.0 million as of June 30, 2026 (10-Q 2026-06-30, Going Concern).
• Cash balance declined 84% in 18 months: from $8.47 million (Dec 31, 2024, 10-K 2025-12-31, Balance Sheet) to $1.35 million (June 30, 2026, 10-Q 2026-06-30, Balance Sheet).
• Working capital flipped negative: from +$4.3 million (Dec 31, 2025, 10-K 2025-12-31, Balance Sheet) to -$2.3 million (June 30, 2026, 10-Q 2026-06-30, Balance Sheet) driven by $3.8 million senior secured debt due October 2026 (10-Q 2026-06-30, Note 5).
• Equity erosion: total stockholders' equity fell from $11.5 million (Dec 31, 2024) to $8.6 million (Dec 31, 2025) to $2.0 million (June 30, 2026) (10-K 2025-12-31 and 10-Q 2026-06-30, Balance Sheets).
• Revenue concentration and concessions: three customers represented 79% of H1 2026 revenue (10-Q 2026-06-30, Concentration of Risks); FY2025 included $884,182 in concessions (43% of gross revenue) related to two strategic customers (10-K 2025-12-31, Revenues, net).
• Financing structure shift: H1 2026 financing was $3.5 million net from senior secured debt (10-Q 2026-06-30, Cash Flows) versus $8.2 million from equity in H1 2025, with the debt carrying a 6-month maturity and fair-value accounting volatility (10-Q 2026-06-30, Note 5).
• GAAP net loss widening annually despite revenue growth: FY2025 net loss $17.9 million vs. FY2024 $14.3 million (10-K 2025-12-31, Statement of Operations).
• Q2 2026 revenue down 66% year-over-year ($490,619 vs. $1,444,599) attributed to prior-quarter concessions (10-Q 2026-06-30, Revenues, net).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual results show revenue growth but widening losses: FY2025 net revenue rose to $2.04 million from $886,485 in FY2024 (10-K 2025-12-31, Statement of Operations), yet the net loss expanded to $17.9 million from $14.3 million, and loss from operations widened to $18.2 million from $14.7 million. Operating expenses increased 30% to $20.2 million driven by G&A (+$3.3 million) and R&D (+$1.4 million) (10-K 2025-12-31, Results of Operations). Quarterly trends diverge: Q1 2026 revenue grew to $480,151 from $296,256 in Q1 2025 (10-Q 2026-03-31, Statement of Operations), but Q2 2026 revenue fell to $490,619 from $1,444,599 in Q2 2025 (10-Q 2026-06-30, Statement of Operations) due to concessions recorded in Q3 2025. H1 2026 net loss was $9.22 million vs. $8.72 million in H1 2025, with the increase driven by $896,914 of debt issuance costs and lower interest income (10-Q 2026-06-30, Other Income (Expense)). Non-GAAP Adjusted EBITDA loss narrowed in H1 2026 to $6.08 million from $7.26 million in H1 2025 (10-Q 2026-06-30, Adjusted EBITDA), but this metric excludes the debt costs and stock compensation that are rising.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Operating cash burn improved year-over-year: H1 2026 used $6.74 million vs. $8.39 million in H1 2025 (10-Q 2026-06-30, Cash Flows); Q1 2026 used $3.42 million vs. $5.36 million in Q1 2025 (10-Q 2026-03-31, Cash Flows). However, total cash position deteriorated because financing inflows collapsed: H1 2026 financing provided $3.48 million (entirely from senior secured debentures) versus $8.22 million in H1 2025 (entirely from common stock) (10-Q 2026-06-30, Cash Flows). FY2025 financing provided $11.15 million from equity (10-K 2025-12-31, Cash Flows). The company held $1.35 million cash at June 30, 2026 (10-Q 2026-06-30, Balance Sheet) against a $3.81 million senior secured debt maturity in October 2026 (10-Q 2026-06-30, Note 5). Investing activities were negligible in all periods (10-K 2025-12-31 and 10-Q 2026-06-30, Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Liquidity and solvency metrics weakened materially in the first half of 2026. Cash dropped to $1.35 million (June 30, 2026) from $4.61 million (Dec 31, 2025) and $8.47 million (Dec 31, 2024) (10-Q 2026-06-30 and 10-K 2025-12-31, Balance Sheets). Current assets fell to $3.01 million from $5.65 million, while current liabilities surged to $5.28 million from $1.36 million, primarily due to the $3.81 million senior secured debt carried at fair value (10-Q 2026-06-30, Balance Sheet). Working capital swung from a $4.29 million surplus to a $2.27 million deficit. Total stockholders' equity declined to $2.04 million from $8.62 million (Dec 31, 2025) and $11.52 million (Dec 31, 2024). The accumulated deficit grew to $200.96 million from $191.74 million (Dec 31, 2025) and $173.81 million (Dec 31, 2024) (10-Q 2026-06-30 and 10-K 2025-12-31, Balance Sheets). Accounts receivable rose to $800K from $239K (Dec 31, 2025), and deferred revenue increased to $650K from $477K (10-Q 2026-06-30, Balance Sheet). No long-term assets or liabilities other than goodwill ($4.18 million constant) and intangibles ($124K net) exist (10-Q 2026-06-30, Balance Sheet).

6. Data Gaps

• Standalone Q3 2025 and Q4 2025 income statements and cash flows (only nine-month and full-year aggregates in 10-K)
• Q3 2026 and Q4 2026 results (not yet filed)
• Revenue breakdown by product (Proof, Verified, PrivacyKey, IDX) or by geography
• Customer churn, net revenue retention, or contract renewal rates
• Detailed maturity schedule for the senior secured debentures beyond the October 2026 maturity
• Terms and potential dilution from the 5.6 million warrants outstanding at June 30, 2026 (10-Q 2026-06-30, Note 8)
• Outcome of the BIPA class action litigation (Perez v. Intellicheck/authID) filed January 2026 (10-Q 2026-06-30, Note 9)